HOLOGIC, INC. (NASDAQ:HOLX) Files An 8-K Other EventsItem 8.01. Other Events.
On January16, 2018, Hologic, Inc. (“Hologic” or the “Company”) issued a press release announcing that the Company has priced and allocated its previously announced private offering of $1billion in aggregate principal amount of senior notes as follows: (i) $600 million aggregate principal amount of additional 4.375% senior notes due 2025 and (ii) $400 million aggregate principal amount of 4.625% senior notes due 2028.
A copy of the press release announcing the pricing of the offering is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
Cautionary Note Regarding Forward-Looking Statements. Except for historical information contained in the press release attached as Exhibit 99.1 hereto, the press release contains forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary notes in the press release regarding these forward-looking statements.
Item 8.01.Financial Statements and Exhibits.
(d) Exhibits.
HOLOGIC INC ExhibitEX-99.1 2 d466052dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Hologic Announces Pricing of Offering of $1 Billion of Senior Notes Marlborough,…To view the full exhibit click here
About HOLOGIC, INC. (NASDAQ:HOLX)
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.
